Sangamo Therapeutics, Inc. (SGMO)

NASDAQ: SGMO · Real-Time Price · USD

0.4959

-0.0342 (-6.45%)

At close: Dec 5, 2025, 4:00 PM EST

0.4974

+0.0015 (0.30%)

After-hours: Dec 5, 2025, 7:59 PM EST

Sangamo Therapeutics Market Cap

Sangamo Therapeutics has a market cap or net worth of $166.87 million as of December 5, 2025. Its market cap has decreased by -57.90% in one year.

Market Cap

166.87M

Enterprise Value

162.68M

1-Year Change

-57.90%

Ranking

#3931

Market Cap Chart

Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from $314.10M to $166.87M, a decrease of -46.87%. That is a compound annual growth rate of -2.43%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	178.30M	-16.21%
Dec 31, 2024	212.80M	120.98%
Dec 29, 2023	96.30M	-81.29%
Dec 30, 2022	514.60M	-52.90%
Dec 31, 2021	1.09B	-50.50%
Dec 31, 2020	2.21B	127.45%
Dec 31, 2019	970.40M	-17.20%
Dec 31, 2018	1.17B	-15.45%
Dec 29, 2017	1.39B	543.50%
Dec 30, 2016	215.40M	-66.32%
Dec 31, 2015	639.50M	-38.53%
Dec 31, 2014	1.04B	21.20%
Dec 31, 2013	858.40M	169.51%
Dec 31, 2012	318.50M	113.76%
Dec 30, 2011	149.00M	-50.38%
Dec 31, 2010	300.30M	12.98%
Dec 31, 2009	265.80M	86.40%
Dec 31, 2008	142.60M	-72.71%
Dec 31, 2007	522.60M	133.30%
Dec 29, 2006	224.00M	118.75%
Dec 30, 2005	102.40M	-32.23%
Dec 31, 2004	151.10M	11.35%
Dec 31, 2003	135.70M	83.13%
Dec 31, 2002	74.10M	-67.54%
Dec 31, 2001	228.30M	-47.02%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	907.15B
Johnson & Johnson	488.22B
AbbVie	403.71B
UnitedHealth Group	300.29B
AstraZeneca	279.81B
Novartis AG	255.73B
Merck & Co.	251.65B
Abbott Laboratories	217.03B

Market Cap Rankings